Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?

This single-center study aimed to retrospectively evaluate the survival outcomes of patients with FIGO stage I clear cell and serous uterine carcinoma according to the type of adjuvant treatment received. The data were collected between 2003 and 2020 and only patients with stage I clear cell or sero...

Descripción completa

Detalles Bibliográficos
Autores principales: Lefebvre, Manon, Duchatelet, Mathilde, El Hajj, Houssein, De Courrèges, Antoine, Wallet, Jennifer, Bellier, Charlotte, Le Tinier, Florence, Le Deley, Marie Cécile, Martinez Gomez, Carlos, Leblanc, Eric, Narducci, Fabrice, Hudry, Delphine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858549/
https://www.ncbi.nlm.nih.gov/pubmed/36661739
http://dx.doi.org/10.3390/curroncol30010090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858549/
https://www.ncbi.nlm.nih.gov/pubmed/36661739
http://dx.doi.org/10.3390/curroncol30010090

Ejemplares similares